Form 8-K · Current report
News Corp 8-K, filed Aug 25, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000187
Summary
News Corp is repurchasing its Nasdaq-listed Class A and Class B common stock under a 2025 program authorized for up to US$1 billion in aggregate, and is providing daily buy-back disclosures to the Australian Securities Exchange. About US$441.3 million of stock has been purchased under the program to date, including 54,641 shares bought back on August 24, 2026.
Key points
- The 2025 Repurchase Program, authorized as of July 15, 2025, allows News Corp to acquire up to an aggregate US$1 billion of its Class A and Class B common stock, with no ASX-listed CDIs to be repurchased.
- On August 24, 2026, News Corp bought back 54,641 shares for total consideration of US$1,676,320.31, bringing cumulative repurchases under the program to 11,134,560 shares.
- Total consideration paid to date under the program is approximately US$441,253,749.
- Goldman Sachs & Co. LLC is named as broker for the buy-back.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.